2.Clean-Up Human Embryonic Stem Cell Lines Using Humanized Culture Condition.
Jin Ah BAEK ; Hye Won SEOL ; Juwon JUNG ; Hee Sun KIM ; Sun Kyung OH ; Young Min CHOI
Tissue Engineering and Regenerative Medicine 2017;14(4):453-464
Human embryonic stem cell (hESC) culture system has been changing culture conditions from conventional to xeno-free for therapeutic cell applications, and N-glycolylneuraminic acid (Neu5Gc) could be a useful indicator of xenogeneic contaminations in hESCs because human cells can no longer produce it genetically. We set up the humanized culture condition using commercially available humanized materials and two different adaptation methods: sequential or direct. SNUhES4 and H1 hESC lines, previously established in conventional culture conditions, were maintained using the humanized culture condition and were examined for the presence of Neu5Gc. The hESCs showed the same morphology and character as those of the conventional culture condition. Moreover, they were negative for Neu5Gc within two passages without loss of pluripotency. This study suggested that this method can effectively cleanse previously established hESC lines, bringing them one step closer to being clinical-grade hESCs.
Human Embryonic Stem Cells*
;
Humans*
;
Methods
3.Maintenance of hPSCs under Xeno-Free and Chemically Defined Culture Conditions
Jung Jin LIM ; Hyung Joon KIM ; Byung Ho RHIE ; Man Ryul LEE ; Myeong Jun CHOI ; Seok Ho HONG ; Kye Seong KIM
International Journal of Stem Cells 2019;12(3):484-496
Previously, the majority of human embryonic stem cells and human induced pluripotent stem cells have been derived on feeder layers and chemically undefined medium. Those media components related to feeder cells, or animal products, often greatly affect the consistency of the cell culture. There are clear advantages of a defined, xeno-free, and feeder-free culture system for human pluripotent stem cells (hPSCs) cultures, since consistency in the formulations prevents lot-to-lot variability. Eliminating all non-human components reduces health risks for downstream applications, and those environments reduce potential immunological reactions from stem cells. Therefore, development of feeder-free hPSCs culture systems has been an important focus of hPSCs research. Recently, researchers have established a variety of culture systems in a defined combination, xeno-free matrix and medium that supports the growth and differentiation of hPSCs. Here we described detailed hPSCs culture methods under feeder-free and chemically defined conditions using vitronetin and TeSR-E8 medium including supplement bioactive lysophospholipid for promoting hPSCs proliferation and maintaining stemness.
Animals
;
Cell Culture Techniques
;
Embryonic Stem Cells
;
Extracellular Matrix
;
Feeder Cells
;
Human Embryonic Stem Cells
;
Humans
;
Induced Pluripotent Stem Cells
;
Pluripotent Stem Cells
;
Stem Cells
4.Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method.
So Jung KIM ; Ji Won JUNG ; Hye Yeong HA ; Soo Kyung KOO ; Eung Gook KIM ; Jung Hyun KIM
Blood Research 2017;52(1):37-43
BACKGROUND: Embryonic stem cells (ESCs) can be expanded infinitely in vitro and have the potential to differentiate into hematopoietic stem cells (HSCs); thus, they are considered a useful source of cells for HSC production. Although several technical in vitro methods for engineering HSCs from pluripotent stem cells have been developed, clinical application of HSCs engineered from pluripotent stem cells is restricted because of the possibility of xenogeneic contamination resulting from the use of murine materials. METHODS: Human ESCs (CHA-hES15) were cultured on growth factor-reduced Matrigel-coated dishes in the mTeSR1 serum-free medium. When the cells were 70% confluent, we initiated HSC differentiation by three methods involving (1) knockout serum replacement (KSR), cytokines, TGFb1, EPO, and FLT3L; (2) KSR, cytokines, and bFGF; or (3) cytokines and bFGF. RESULTS: Among the three differentiation methods, the minimal number of cytokines without KSR resulted in the greatest production of HSCs. The optimized method resulted in a higher proportion of CD34⁺CD43⁺ hematopoietic progenitor cells (HPCs) and CD34⁺CD45⁺ HPCs compared to the other methods. In addition, the HSCs showed the potential to differentiate into multiple lineages of hematopoietic cells in vitro. CONCLUSION: In this study, we optimized a two-step, serum-free, animal protein-free, KSR-free, feeder-free, chemically defined monolayer culture method for generation of HSCs and hematopoietic stem and progenitor cells (HSPCs) from human ESCs.
Animals
;
Cytokines
;
Embryonic Stem Cells
;
Hematopoietic Stem Cells*
;
Human Embryonic Stem Cells*
;
Humans*
;
In Vitro Techniques
;
Methods*
;
Pluripotent Stem Cells
;
Stem Cells
5.Directing Human Embryonic Stem Cells towards Functional Endothelial Cells Easily and without Purification.
Chang Hyun GIL ; Byeong Seong KI ; Joseph SEO ; Jong Jin CHOI ; Hana KIM ; In Gul KIM ; A Ra JUNG ; Won Young LEE ; Youngsok CHOI ; Kwideok PARK ; Sung Hwan MOON ; Hyung Min CHUNG
Tissue Engineering and Regenerative Medicine 2016;13(3):274-283
Hemangioblasts or blood islands only arise in early development thereby the sources to obtain these bi-potential cells are limited. While previous studies have isolated both lineages in vitro through the hemangioblast, derivation efficiency was rather low due to cellular damage attributed by enzyme usage and fluorescent activated cell sorting (FACS). This study focused on avoiding the use of damaging factors in the derivation of endothelial cells (ECs). Single cell H9-human embryonic stem cells (hESCs) were obtained by using a mild dissociation protocol then human embryoid body (hEB) formation was performed under hemangioblast differentiation conditions. The hEBs were subjected to a two-stage cytokine treatment procedure. Subsequent culture of the adhesive cells in day 4 hEBs gave arise to a seemingly pure population of ECs. The hESC-derived ECs were characterized by identifying signature endothelial gene and protein markers as well as testing for in vitro functionality. Furthermore, in vivo functionality was also confirmed by transplanting the cells in hindlimb ischemic murine models. We demonstrate that the genetic change required for EC derivation precedes blast colony formation. Furthermore, cell damage was prevented by abating enzyme usage and FACS, resulting in a high yield of ECs upon adhesion. Under this method, confluent cultures of ECs were obtainable 4 days after hEB formation which is significantly faster than previous protocols.
Adhesives
;
Animals
;
Embryoid Bodies
;
Embryonic Stem Cells
;
Endothelial Cells*
;
Hemangioblasts
;
Hindlimb
;
Human Embryonic Stem Cells*
;
Humans*
;
In Vitro Techniques
;
Islands
;
Methods
6.Transcriptional Profiles of Imprinted Genes in Human Embryonic Stem Cells During In vitro Differentiation.
Sang Wook PARK ; Hyo Sang DO ; Dongkyu KIM ; Ji Yun KO ; Sang Hun LEE ; Yong Mahn HAN
International Journal of Stem Cells 2014;7(2):108-117
BACKGROUND AND OBJECTIVES: Genomic imprinting is an inheritance phenomenon by which a subset of genes are expressed from one allele of two homologous chromosomes in a parent of origin-specific manner. Even though fine-tuned regulation of genomic imprinting process is essential for normal development, no other means are available to study genomic imprinting in human during embryonic development. In relation with this bottleneck, differentiation of human embryonic stem cells (hESCs) into specialized lineages may be considered as an alternative to mimic human development. METHODS AND RESULTS: In this study, hESCs were differentiated into three lineage cell types to analyze temporal and spatial expression of imprinted genes. Of 19 imprinted genes examined, 15 imprinted genes showed similar transcriptional level among two hESC lines and two human induced pluripotent stem cell (hiPSC) lines. Expressional patterns of most imprinted genes were varied in progenitors and fully differentiated cells which were derived from hESCs. Also, no consistence was observed in the expression pattern of imprinted genes within an imprinting domain during in vitro differentiation of hESCs into three lineage cell types. CONCLUSIONS: Transcriptional expression of imprinted genes is regulated in a cell type-specific manner in hESCs during in vitro differentiation.
Alleles
;
Embryonic Development
;
Embryonic Stem Cells*
;
Female
;
Genomic Imprinting
;
Human Development
;
Humans
;
Parents
;
Pluripotent Stem Cells
;
Pregnancy
;
Wills
7.Role of BET Bromodomain in Hematopoietic Differentiation from hESCs.
Zi-Cen FENG ; Yu-Qi WEN ; Meng-Ge WANG ; Qian TU ; Hong-Tao WANG ; Zheng-Yu WANG ; Jia-Xi ZHOU
Journal of Experimental Hematology 2018;26(4):1186-1193
OBJECTIVETo explore the role of bromodomain and extra terminal (BET) bromodomain in hematopoietic differentiation from human enbryonic stem cells (hESC).
METHODSThe effect of BET hematopoietic inhibitor I-BET151 on hematopoietic differentiation from hESC was detected by using a monolayer hematopoietic defferentiation model, immunofluorescence, flow cytometry and real-time PCR; moreover the role of I-BET151 in process of hematopoietic differentiation was explored by adding I-BET151 in different differentiation stages.
RESULTSThe analysis results of immunofluorescence, flow cytometry and real-time PCR showed that I-BET 151 significantly inhibited the generation of CD43 positive hematopoietic stem and progenitor cells (HSPCs). It was found that the addition of I-BET 151 in different stages, including APLNR lateral plate mesoderm production, CD34CD31 hemogenic endothelium (HEP) generation and endothelial-to-hematopoietic transition, significantly suppressed the generation of CD43 positive hematopoietic progenitor cells.
CONCLUSIONI-BET 151 inhibites hematopoietic differentiation from hESCs at several stages, suggesting that the BET bromodomain plays important roles in multiple stages of hematopoietic differentiation from hESCs.
Apelin Receptors ; Cell Differentiation ; Flow Cytometry ; Hemangioblasts ; Hematopoietic Stem Cells ; Human Embryonic Stem Cells ; Humans
8.Ethical Issues on Embryonic Stem Cell Research.
Journal of the Korean Medical Association 2005;48(10):1005-1012
Harvesting stem cells is inevitably associated with destruction of early embryos. There have been continuing challenges to devaluate the moral status of early embryos. The distinction between preembryo and embryo was mainly based on the lack of individuation. The term preembryo had been introduced by a frog embryologist and then was literally spread around the world because of policy reasons. Thus the definition of preembryo is not yet complete and the term has not yet been used in most medical textbooks including textbooks of human embryology. Preembryo is a period during human development and therefore should be regarded as valuable as an early form of human life. Obtaining embryonic stem cells using SCNT (Somatic Cell Nuclear Transfer) is often called therapeutic cloning as opposed to reproductive cloning that produces human beings by SCNT. Therapeutic cloning used same SCNT to produce human embryos, and therefore it is essentially a process of human cloning. Human cloning is prohibited in most of the world due to ethical issues. Cloning primates including humans using SCNT has not been successful, however, recently there has been a remarkable progress with the help of improved technology of therapeutic cloning. Other countries also recognize the enormous potentials of cloned embryonic stem cells, but no country other than Korea and the UK has allowed therapeutic cloning for fear of the "slippery slope" towards human reproductive cloning. Ongoing researches of therapeutic cloning should be monitored carefully and a broad consensus is needed before allowing further therapeutic cloning. Eventually more ethical ways of obtaining embryonic stem cells should be developed.
Clone Cells
;
Cloning, Organism
;
Consensus
;
Embryology
;
Embryonic Stem Cells*
;
Embryonic Structures
;
Ethics*
;
Human Development
;
Humans
;
Individuation
;
Korea
;
Primates
;
Stem Cell Research*
;
Stem Cells
9.New Advances in Human X Chromosome Status from a Developmental and Stem Cell Biology.
Benjamin PATTERSON ; Yoshiaki TANAKA ; In Hyun PARK
Tissue Engineering and Regenerative Medicine 2017;14(6):643-652
Recent advances in stem cell biology have dramatically increased the understanding of molecular and cellular mechanism of pluripotency and cell fate determination. Additionally, pluripotent stem cells (PSCs), including embryonic stem cells and induced pluripotent stem cells, arose as essential resources for disease modeling and cellular therapeutics. Despite these advancements, the epigenetic dysregulation in pluripotency such as the imprinting status, and X chromosome dosage compensation, and its consequences on future utility of PSCs yet remain unresolved. In this review, we will focus on the X chromosome regulation in human PSCs (hPSCs). We will introduce the previous findings in the dosage compensation process on mouse model, and make comparison with those of human systems. Particularly, the X chromosome activation status of human preimplantation embryos, and the regulation of the active X chromosome by human specific lincRNA, X Active Coating Transcript (XACT), will be discussed. We will also discuss the recent findings on higher order X chromosome architecture, and abnormal X chromosome status in hPSCs.
Animals
;
Biology*
;
Blastocyst
;
Chromosomes, Human, X*
;
Compensation and Redress
;
Embryonic Stem Cells
;
Epigenomics
;
Humans*
;
Induced Pluripotent Stem Cells
;
Mice
;
Pluripotent Stem Cells
;
Stem Cells*
;
X Chromosome
10.Differential MicroRNA Expression Profile of Human Embryonic Stem Cell-Derived Cardiac Lineage Cells.
Yoon Young KIM ; Harry MIN ; Hoon KIM ; Young Min CHOI ; Hung Ching LIU ; Seung Yup KU
Tissue Engineering and Regenerative Medicine 2017;14(2):163-169
MicroRNAs (miRNAs) are small non-coding RNA molecules that participate in transcriptional and post-transcriptional regulation of gene expression. miRNAs have numerous roles in cellular function including embryonic development. Human embryonic stem cells (hESCs) are capable of self-renewal and can differentiate into most of cell types including cardiomyocytes (CMs). These characteristics of hESCs make them considered as an important model for studying human embryonic development and tissue specific differentiation. In this study, we tried to demonstrate the profile of miRNA expression in cardiac differentiation from hESCs. To induce differentiation, we differentiated hESCs into CMs by direct differentiation method and characterized differentiated cells. To analyze the expression of miRNAs, we distinguished (days 4, 8, 12, 16, 20, 24, 28) and isolated RNAs from each differentiation stage. miRNA specific RT-qPCR was performed and the expression profile of miR-1, -30d, -133a, -143, -145, -378a, -499a was evaluated. The expression of all miRs was up-regulated at day 8. miR-143 and -145 expression was also up-regulated at the later stage of differentiation. Only miR-378a expression returned to undifferentiated hESC levels at the other stages of differentiation. In conclusion, we elucidated the expression profile of miRNAs during differentiation into cardiomyocytes from hESCs. Our findings demonstrate the expression of miRNAs was stage-dependent during differentiation and suggest that the differentiation into CMs can be regulated by miRNAs through direct or indirect pathway.
Embryonic Development
;
Female
;
Gene Expression Regulation
;
Human Embryonic Stem Cells
;
Humans*
;
Methods
;
MicroRNAs*
;
Myocytes, Cardiac
;
Pregnancy
;
RNA
;
RNA, Small Untranslated